Latest Accounting News

Rivco Australia has reported a remarkable 135% increase in net profit for the year ended 31 December 2025, alongside fully franked dividends and a solid net asset value per share.

Future Generation Global Limited reported a 50% drop in net profit for 2025 but maintained strong investment portfolio growth and declared a special fully franked dividend, while continuing its significant social impact contributions.

Elanor Investors Group reported a $24.5 million net loss for the half year to December 2024, grappling with debt covenant breaches and defaults. The group has struck a $125 million recapitalisation agreement with Rockworth Capital Partners to stabilise its balance sheet and pursue growth.

Mach7 Technologies reported a 23% drop in revenue to $13.65 million for H1 FY26, alongside a sharp increase in net loss to $5.75 million, as it embarks on a strategic commercial reset and expands its Asia-based engineering capabilities.

4DMedical Limited’s half-year report reveals rapid commercial traction following FDA clearance of its CT:VQ™ imaging technology, alongside a $150 million institutional placement that bolsters its cash reserves for global expansion.

PPK Group Limited has reported a remarkable turnaround with a $10.5 million profit for H1 2026, driven by a significant non-cash gain from its Li-S Energy investment and strategic portfolio adjustments.

Auric Mining has exceeded its 2026 gold production budgets at the Munda Starter Pit, delivering strong early results that validate the economic potential of the larger Munda Main Pit.

WT Financial Group has reported robust half-year results for H1 FY2026, marked by a 20.8% increase in underlying net profit after tax and a fully franked interim dividend. The company’s strategic pivot to a business-to-business advice model and its Investco joint venture underpin its growth trajectory.

Atlas Pearls reports a challenging first half of FY26 with a 27% drop in revenue and a net loss of $5.2 million, driven by weaker market demand and a shift towards lower-grade pearl sales.

Biotron Limited reported a half-year loss as it completed the acquisition of Sedarex Limited and advanced its Hepatitis B drug candidate BIT-HBV001, backed by a $2.5 million capital raise. The company faces material uncertainty over its going concern status, hinging on securing further funding.

BrainChip Holdings Ltd reported a striking 374% jump in revenue for 2025, yet the company still posted a substantial operating loss of over US$20 million. The results reveal mixed signals for investors watching the semiconductor innovator’s path forward.

Gryphon Capital Income Trust reported a robust half-year profit increase alongside successful capital raises, positioning the fund for expanded investment in Australian RMBS and ABS markets.